Gasdermin D promotes influenza virus-induced mortality through neutrophil amplification of inflammation

Samuel Speaks1, Ashley Zani1,2, Abigail Solstad1

  • 1Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH 43210.

Insights

Gasdermin D (GSDMD) amplifies lung inflammation and severity during influenza virus infection by promoting neutrophil responses. Targeting GSDMD may offer new treatments for severe flu.

Area of Science:

  • Immunology
  • Virology
  • Molecular Biology

Background:

  • Influenza virus infection triggers inflammasome pathways, impacting disease severity.
  • Gasdermin D (GSDMD) is a key protein activated by inflammasomes, forming pores in cell membranes.

Approach:

  • Investigated GSDMD's role in influenza using GSDMD knockout (KO) mice and wild-type (WT) mice.
  • Analyzed lung histopathology, viral loads, gene expression (transcriptomics), and neutrophil responses.
  • Utilized neutrophil depletion experiments in WT mice to confirm GSDMD's mechanism.

Key Points:

  • GSDMD deficiency in mice significantly reduced influenza-induced weight loss, lung damage, and mortality.
  • Transcriptomics revealed decreased inflammatory gene signatures and neutrophil infiltration in GSDMD KO mice.
  • Neutrophil depletion mimicked GSDMD KO protection in WT mice, highlighting neutrophils as critical mediators.

Conclusions:

  • GSDMD promotes lung neutrophil recruitment and activation, exacerbating influenza pathogenesis.
  • The GSDMD-neutrophil axis represents a novel therapeutic target for severe influenza infections.